Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma

European Journal of Haematology

Volumn 78, Issue 5, 2007, Pages 399-404

  Bonnet, Christophe ^a   Beguin, Yves ^a,b   Fassotte, Marie France ^a   Seidel, Laurence ^a   Luyckx, Françoise ^a   Fillet, Georges ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b FNRS   (Belgium)

Author keywords

CA125; Hodgkin's disease; Non Hodgkin's lymphoma

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CA 125 ANTIGEN; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BONE MARROW; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; FEMALE; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS;

EID: 34147148119     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00843.x     Document Type: Article

References (19)

1. Zacharos ID, Efstathiou SP, Petreli E, Georgiou G, Tsioulos DI, Mastorantonakis SE, Christakopoulou I, Roussou PP. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. Eur J Haematol 2002;69:221-6.
2. Lazzarino M, Orlandi E, Klersy C, Astori C, Brusamolino E, Corso A, Bellio L, Gargantini L, Morra E, Bernasconi C. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Cancer 1998;82:576-82.
3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-94.
4. Bairey O, Blickstein D, Stark P, Prokocimer M, Nativ HM, Kirgner I, Shaklai M. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma. Leuk Lymphoma 2003;44:1733-8.
5. Vlasveld LT, Ermens AAM, Sonnenberg AA, Pauwels P. Elevated serum Ca-125 concentrations due to expression by a diffuse large B-cell lymphoma. Ann Clin Biochem 2000;37:545-8.
6. Zidan J, Hussein O, Basher W, Zohar S. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma. Oncologist 2004;9:417-21.
7. Benboubker L, Valat C, Linassier C, Cartron G, Delain M, Bout M, Fetissof F, Lafranq T, Lamagnere JP, Colombat P. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels. Ann Oncol 2000;11:1485-91.
8. Ravoet C, Dargent JL, Le Moine F, Feremans W. CA-125 in primary mediastinal B-cell lymphoma with sclerosis. J Clin Oncol 1995;13:530-1.
9. Dilek I, Ayakta H, Demir C, Meral C, Ozturk M. CA 125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies. Clin Lab Haematol 2005;27:51-5.
10. Fehm T, Beck E, Valerius T, Gramatzki M, Jager W. CA 125 elevations in patients with malignant lymphomas. Tumour Biol 1998;19:283-9.
11. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
12. Schnitzer B. Classification of lymphomas. CRC Crit Rev Clin Lab Sci 1978;9:123-78.
13. Cox DR. Regression model and lifetables. J R Stat Soc 1972;34:187-220.
14. Pabst T, Ludwig C. CA-125: a tumor marker in non-Hodgkin's lymphomas? J Clin Oncol 1995;13:1827-8.
15. Morra E. The biological markers of non-Hodgkin's lymphomas: their role in diagnosis, prognostic assessment and therapeutic strategy. Int J Biol Markers 1999;14:149-53.
16. Kutluk T, Varan A, Erbas B, Buyukpamukcu M. Serum CA 125 levels in children with non-Hodgkin's lymphoma. Pediatr Hematol Oncol 1999;16:311-9.
17. Watanabe M, Kanda T, Takatama M, Iwai T, Naito I, Fukuda T, Hirai S. An autopsy case of malignant lymphoma with a high serum CA 125 level occurring only in the brain and pericardium. J Med 1996;27:221-7.
18. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258-65.
19. Haioun C, Itti E, Rahmouni A, et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005;106:1376-81.